drugset / Trial / NCT06572449

Study to Assess Safety and Effectiveness of Slowly Increasing Dose and Food Effect of KarXT in Participants With Schizophrenia

NCT06572449

Phase 3 Completed 173 enrolled Karuna Therapeutics, Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety and efficacy of slowly increasing dose and food effect of KarXT in adult participants with schizophrenia.

Timeline

Start
2024-10-28
Primary completion
2025-03-13
Completion
2025-03-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Trospium Small molecule

Indications